IP Library › Assignment 035750/0951
Patent Assignment
Reel/Frame 035750/0951

Change of Name

Recorded: 2015-05-21 Pages: 8
Assignor
CHANRX CORP.
Executed: 2015-02-18
Assignee
LAGUNA PHARMACEUTICALS, INC.
4225 EXECUTIVE SQUARE, STE. 960, LA JOLLA, CALIFORNIA, 92037
Covered Properties (42)
Methods for Preventing or Treating Cardiac Arrhythmia
Pharmaceutical Compositions Containing Vanoxerine
Pharmaceutical Compositions for Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and/or Maintaining Normal Sinus Rhythm in Mammals
Novel Piperazine Compounds, Pharmaceutical Compositons Containing the Same and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals
Pharmaceutical Compositions Containing Piperazine Compounds in Combination with a P450 Inhibitor and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining...
Pharmaceutical Compositions Containing Enantiomerically Pure and/or Racemic Mixtures of Chiral Piperazine Compounds and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia....
Novel Metabolites of Vanoxerine Compounds, Pharmaceutical Compositions Containing the Same and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals
Methods of Remote Monitoring of Self-Administration of Vanoxerine for Terminating Acute Episodes of Cardiac Arrhythmia in Mammals
Methods of Self-Administration of Vanoxerine for Terminating Acute Episodes of Cardiac Arrhythmia in Mammals
Vanoxerine for Self-Administration for Terminating Acute Episodes of Cardiac Arrhythmia in Mammals
Pharmaceutical Compositions Containing Vanoxerine and P450 Inhibitors and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals Through Administration of Said Compositions
Methods for Calibrating the Administration of Vanoxerine for Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rythm in Mammals
Methods of Treatment of Cardiac Arrhythmias Using Vanoxerine and Modification of Diet
Pharmaceutical Compositions Comprising Vanoxerine and Antianginal Compounds, and Methods of Administration of the Same for Treating Episodes of Cardiac Arrhythmia, Maintaining Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia, and Treatment of Chronic Cardiac Arrhythmia in Mammals
Methods of Administration of Single Doses of Vanoxerine to Terminate Acute Episodes of Cardiac Arrhythmia
Pharmaceutical Compositions Comprising Vanoxerine and Methods of Use for Loading Phase and Chronic Administration
Pharmaceutical Compositions for Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia, and/or Maintaining Normal Sinus Rhythm in Mammals
Methods for Treating Cardiac Arrhythmia
Patent: 6,743,797 →
Application: 10/079,485 →
Publication: US 2003/0162793
Methods for preventing or treating cardiac arrhythmia
Application: 10/742,822 →
Publication: US 2004/0138146
Methods for Treating Cardiac Arrhythmia
Patent: 7,700,600 →
Application: 11/878,611 →
Publication: US 2008/0214554
Methods for preventing or treating cardiac arrhythmia
Application: 12/591,180 →
Publication: US 2010/0069403
Pharmaceutical compositions containing vanoxerine
Application: 12/801,960 →
Publication: US 2012/0010216
Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
Application: 12/805,460 →
Publication: US 2012/0028992
Methods for Reducing the Recurrence of Cardiac Arrhythmia
Patent: 8,450,325 →
Application: 13/158,791 →
Publication: US 2011/0237604
Novel Piperazine Compounds, Pharmaceutical Compositions Containing the Same and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals
Application: 14/437,485 →
Publication: US 2015/0336917
Pharmaceutical Compositions Containing Piperazine Compounds in Combination with a P450 Inhibitor and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals Through Administration of Said Compositions
Application: 14/437,490 →
Publication: US 2015/0283131
Pharmaceutical Compositions Containing Enantiomerically Pure and/or Racemic Mixtures of Chiral Piperazine Compounds and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals Through Administration of Said Compositions
Application: 14/437,493 →
Publication: US 2015/0290188
Novel Piperazine Compounds, Pharmaceutical Compositions Containing the Same and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals
Application: 61/712,620 →
Pharmaceutical Compositions Containing Vanoxerine and CYP3A4 Inhibitors and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals Through Administration of Said Compositions
Application: 61/816,214 →
Pharmaceutical Compositions Containing Piperazine Compounds in Combination with a CYP3A4 Inhibitor and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals Through Administration of Said Compositions
Application: 61/818,165 →
Pharmaceutical Compositions Containing Enantiomerically Pure and/or Racemic Mixtures of Chiral Piperazine Compounds and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals Through Administration of Said Compositions
Application: 61/843,484 →
Methods for Calibrating the Administration of Vanoxerine for Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals
Application: 61/904,753 →
Methods of Self-Administration of Vanoxerine for Terminating Acute Episodes of Cardiac Arrhythmia in Mammals
Application: 61/904,796 →
Methods of Treatment of Cardiac Arrhythmias Using Vanoxerine and Modification of Diet
Application: 61/904,813 →
Methods of Using Vanoxerine and P450 Inhibitors for Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals
Application: 61/904,949 →
Methods of Remote Monitoring of Self-Administration of Vanoxerine for Terminating Acute Episodes of Cardiac Arrhythmia in Mammals
Application: 61/905,017 →
Novel Metabolites of Vanoxerine Compounds, Pharmaceutical Compositions Containing the Same and Methods of Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia and Maintaining Normal Sinus Rhythm in Mammals
Application: 61/905,039 →
Pharmaceutical Compositions Comprising Vanoxerine and Antianginal Compounds, and Methods of Administration of the Same for Treating Episodes of Cardiac Arrhythmia, Maintaining Normal Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia, and Treatment of Chronic Cardiac Arrhythmia in Mammals
Application: 61/905,054 →
Methods of Administration of Single Doses of Vanoxerine to Terminate Acute Episodes of Cardiac Arrhythmia
Application: 61/915,792 →
Vanoxerine for Self-Administration for Terminating Acute Episodes of Cardiac Arrhythmia in Mammals
Application: 61/915,829 →
Pharmaceutical Compositions Comprising Vanoxerine and Methods of Use for Loading Phase and Chronic Administration
Application: 61/936,049 →
Pharmaceutical Compositions for Terminating Acute Episodes of Cardiac Arrhythmia, Restoring Sinus Rhythm, Preventing Recurrence of Cardiac Arrhythmia, and/or Maintaining Normal Sinus Rhythm in Mammals
Application: 61/936,086 →
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 5, 2004
From: BROWN, ARTUR M.
To: CHANTEST, INC.; HEALTH AND HUMAN SERVICES, THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF
Reel/Frame 015659/0085 →
Assignment of Assignor's Interest Sep 29, 2008
From: CHANTEST CORPORATION
To: CHANRX CORP.
Reel/Frame 021590/0632 →
Assignment of Assignor's Interest Jul 27, 2010
From: BROWN, ARTHUR M.
To: CHANRX
Reel/Frame 024745/0296 →
Assignment of Assignor's Interest Aug 23, 2010
From: BROWN, ARTHUR M.
To: CHANRX
Reel/Frame 024869/0398 →
Assignment of Assignor's Interest Dec 7, 2012
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 029424/0434 →
Assignment of Assignor's Interest Apr 24, 2013
From: CHANTEST CORPORATION
To: CHANRX CORP.
Reel/Frame 030278/0861 →
Assignment of Assignor's Interest Apr 24, 2013
From: BROWN, ARTHUR M.
To: CHANTEST, INC.
Reel/Frame 030278/0563 →
Assignment of Assignor's Interest Apr 24, 2013
From: CHAND, NARESH
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 030278/0687 →
Assignment of Assignor's Interest May 24, 2013
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 030480/0153 →
Assignment of Assignor's Interest Mar 25, 2014
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 032521/0629 →
Assignment of Assignor's Interest Mar 25, 2014
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 032521/0857 →
Assignment of Assignor's Interest Mar 25, 2014
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 032520/0317 →
Assignment of Assignor's Interest Mar 25, 2014
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 032520/0193 →
Assignment of Assignor's Interest Mar 25, 2014
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 032520/0411 →
Assignment of Assignor's Interest Mar 25, 2014
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 032521/0283 →
Assignment of Assignor's Interest Mar 25, 2014
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 032520/0888 →
Assignment of Assignor's Interest Jul 16, 2014
From: HOWARD C. DITTRICH; RAJESH KHOSLA
To: CHANRX CORPORATION
Reel/Frame 033319/0713 →
Assignment of Assignor's Interest Jul 16, 2014
From: BROWN, ARTHUR M.; DITTRICH, HOWARD C.
To: CHANRX CORPORATION
Reel/Frame 033321/0634 →
Assignment of Assignor's Interest Jun 5, 2015
From: BROWN, ARTHUR M.
To: CHANRX CORPORATION
Reel/Frame 035793/0752 →
Assignment of Assignor's Interest Oct 9, 2015
From: CHAND, NARESH
To: THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 036766/0558 →
Assignment of Assignor's Interest Oct 9, 2015
From: BROWN, ARTHUR M.
To: CHANTEST, INC.
Reel/Frame 036766/0520 →
Assignment of Assignor's Interest Oct 9, 2015
From: CHANTEST CORPORATION
To: CHANRX, CORP.
Reel/Frame 036766/0515 →